Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia
- 1 September 1993
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 5 (1) , 51-55
- https://doi.org/10.1038/ng0993-51
Abstract
Central core disease (CCD) of muscle is an inherited myopathy which is closely associated with malignant hyperthermia (MH) in humans. CCD has recently been shown to be tightly linked to the ryanodine receptor gene (RYR1) and mutations in this gene are known to be present in MH. Mutation screening of RYR1 has led to the identification of two previously undescribed mutations in different CCD pedigrees. One of these mutations was also detected in an unrelated MH pedigree whose members are asymptomatic of CCD. The data suggest a model to explain how a single mutation may result in two apparently distinct clinical phenotypes.Keywords
This publication has 25 references indexed in Scilit:
- The Sixth International Malignant Hyperthermia WorkshopAnesthesiology, 1993
- Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17qGenomics, 1992
- Primary structure and distribution of a novel ryanodine receptor/calcium release channel from rabbit brainFEBS Letters, 1992
- A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermiaGenomics, 1991
- Evidence for genetic heterogeneity in malignant hyperthermia susceptibilityGenomics, 1991
- Evidence for linkage of the central core disease locus to the proximal long arm of human chromosome 19Genomics, 1991
- Central core disease: Ultrastructure of the sarcoplasmic reticulum and T‐tubulesMuscle & Nerve, 1989
- Central Core DiseaseMedicine, 1987
- Central core disease. A correlated genetic, histochemical, ultramicroscopic, and biochemical study.Journal of Neurology, Neurosurgery & Psychiatry, 1975
- CENTRAL CORE DISEASE OR NOT?Brain, 1973